Terms: = Uterine cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Treatment
5 results:
1. Up-regulation of inflammation-related LncRNA-il7r predicts poor clinical outcome in patients with cervical cancer.
Fan Y; Nan Y; Huang J; Zhong H; Zhou W
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29720427
[TBL] [Abstract] [Full Text] [Related]
2. The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids.
Nagy B; Timár G; Józwiak-Hagymásy J; Kovács G; Merész G; Vámossy I; Ágh T; László Á; Vokó Z; Kaló Z
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():75-81. PubMed ID: 24568866
[TBL] [Abstract] [Full Text] [Related]
3. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract] [Full Text] [Related]
4. Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.
Ambrus JL; Dembinski W; Ambrus JL; Sykes DE; Akhter S; Kulaylat MN; Islam A; Chadha KC
Cancer; 2003 Dec; 98(12):2730-3. PubMed ID: 14669296
[TBL] [Abstract] [Full Text] [Related]
5. Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer.
Sugiyama T; Yakushiji M; Noda K; Ikeda M; Kudoh R; Yajima A; Tomoda Y; Terashima Y; Takeuchi S; Hiura M; Saji F; Takahashi T; Umesaki N; Sato S; Hatae M; Ohashi Y
Oncology; 2000; 58(1):31-7. PubMed ID: 10644938
[TBL] [Abstract] [Full Text] [Related]
